Paget's disease of bone involves abnormal bone remodelling, producing structurally weaker bone with enlarged but fragile structure. The pelvis, femur, tibia, and spine are the most commonly affected sites. When Paget's disease affects weight-bearing bones, the risk of pathological fracture -- fracture occurring under normal loading conditions because the bone cannot sustain normal loads -- becomes a significant management concern.
A walking cane in this context has a more specific function than in most other conditions: reducing the load through structurally compromised bone during each step, directly reducing pathological fracture risk.
Skeletal Load in Paget's Disease
Normal walking loads on the hip joint during the stance phase: approximately 3-5x body weight. For a person of 80kg, this is 240-400kg of force through the hip joint per step, repeated thousands of times per day. Pagetoid bone of the femoral head or proximal femur is less able to sustain these cyclic loads than normal bone.
A walking cane on the contralateral side reduces peak load by 15-25% per step. For bone that is 30-40% weaker than normal (which is within the range for Pagetoid bone), this reduction meaningfully shifts the loading ratio away from the fracture threshold.
Which Bones Are Most Relevant
| Affected Area | Load Concern | Cane Indication |
|---|---|---|
| Femoral head / proximal femur | Pathological fracture of femoral neck or shaft | Strong -- contralateral cane reduces hip load |
| Pelvis | Acetabular fracture, hip instability | Strong -- cane reduces load on pelvic ring |
| Tibia | Anterior bow fracture (chalk-stick fracture) | Moderate -- cane reduces axial tibial load |
| Lumbar spine | Vertebral compression, spinal stenosis | Moderate -- cane reduces postural load |
| Skull / facial bones | Hearing loss, nerve compression | Not relevant to walking load |
Bisphosphonate Therapy and Cane Use
Bisphosphonate therapy (pamidronate, zoledronate, risedronate) is the primary treatment for Paget's disease -- it reduces the abnormal bone turnover rate and, over months, produces stronger remodelled bone. During bisphosphonate treatment, pathological fracture risk decreases. However, bone strengthening from bisphosphonate therapy takes 3-6 months to manifest structurally. During this period, cane use continues at the same level.
After confirmed biochemical and radiological response (normalised alkaline phosphatase, confirmed on X-ray), the orthopaedic specialist may modify the load-bearing protocol. Cane tapering in Paget's disease should be based on specialist assessment, not symptom improvement alone -- pain reduction precedes structural strengthening.
Cane Specifications for Paget's Disease
For load-bearing cane use in Paget's disease, shaft stiffness and stability are the primary specifications. A cane that deflects or wobbles under load does not provide reliable load reduction:
- Collet mechanism (0mm lateral play): ensures the shaft is stable under the loads required for meaningful joint load reduction
- Solid hardwood shaft (oak or wenge): higher stiffness than aluminium at equivalent weight, resists bending under asymmetric load
- Steady Tip (large contact patch): prevents the tip from slipping when the cane is bearing meaningful load, which is the mechanism for slip-related falls when a cane is used for genuine load-bearing
View the DaiWalk range for load-bearing cane specifications appropriate for Paget's disease management.
